4-3493411-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBS1_SupportingBS2_Supporting
The NM_173660.5(DOK7):c.1425G>T(p.Trp475Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000254 in 1,598,000 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_173660.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOK7 | NM_173660.5 | c.1425G>T | p.Trp475Cys | missense_variant | 7/7 | ENST00000340083.6 | NP_775931.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOK7 | ENST00000340083.6 | c.1425G>T | p.Trp475Cys | missense_variant | 7/7 | 1 | NM_173660.5 | ENSP00000344432.5 | ||
DOK7 | ENST00000643608.1 | c.993G>T | p.Trp331Cys | missense_variant | 5/8 | ENSP00000495701.1 | ||||
DOK7 | ENST00000515886.5 | c.495G>T | p.Trp165Cys | missense_variant | 4/4 | 2 | ENSP00000492194.1 | |||
DOK7 | ENST00000507039.5 | c.*646G>T | 3_prime_UTR_variant | 7/7 | 2 | ENSP00000423614.1 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152200Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.000243 AC: 51AN: 209818Hom.: 1 AF XY: 0.000241 AC XY: 28AN XY: 116082
GnomAD4 exome AF: 0.000252 AC: 365AN: 1445682Hom.: 2 Cov.: 88 AF XY: 0.000259 AC XY: 186AN XY: 718070
GnomAD4 genome AF: 0.000269 AC: 41AN: 152318Hom.: 0 Cov.: 35 AF XY: 0.000201 AC XY: 15AN XY: 74484
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 10 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 15, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2022 | This sequence change replaces tryptophan, which is neutral and slightly polar, with cysteine, which is neutral and slightly polar, at codon 475 of the DOK7 protein (p.Trp475Cys). This variant is present in population databases (rs777626370, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with DOK7-related conditions. ClinVar contains an entry for this variant (Variation ID: 452145). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 25, 2017 | A variant of uncertain significance has been identified in the DOK7 gene. The W475C variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The W475C variant is observed in 4/5282 (0.1%) alleles from individuals of Latino background, including 1 homozygous individual in large population cohorts (Lek et al., 2016). The W475C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In silico analysis predicts this variant is probably damaging to the protein structure/function. However, this substitution occurs at a position that is not conserved. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at